Skip to main content
TipRanks
Go Ultimate75% OFF

Puma Biotechnology (PBYI) Stock Statistics & Valuation Metrics

679 Followers

Total Valuation

Puma Biotechnology has a market cap or net worth of $368.09M. The enterprise value is $423.74M.

Market Cap
$368.09M
Enterprise Value
$423.74M

Share Statistics

Puma Biotechnology has 51,698,357 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
51,698,357
Owned by Insiders
15.78%
Owned by Institutions
62.69%

Financial Efficiency

Puma Biotechnology’s return on equity (ROE) is 0.24 and return on invested capital (ROIC) is 20.41%.

Return on Equity (ROE)
0.24
Return on Assets (ROA)
0.14
Return on Invested Capital (ROIC)
20.41%
Return on Capital Employed (ROCE)
0.28
Revenue Per Employee
1.28M
Profits Per Employee
173.80K
Employee Count
179
Asset Turnover
1.06
Inventory Turnover
10.55

Valuation Ratios

The current PE Ratio of Puma Biotechnology is 14.95. Puma Biotechnology’s PEG ratio is -0.42.

PE Ratio
14.95
PS Ratio
1.59
PB Ratio
2.51
Price to FCF
7.99
Price to Operating Cash Flow
7.98
PEG Ratio
-0.42

Income Statement

In the last 12 months, Puma Biotechnology had revenue of 228.37M and earned 31.11M in profits. Earnings per share was 0.62.

Revenue
228.37M
Gross Profit
170.21M
Operating Income
37.30M
Pretax Income
35.78M
Net Income
31.11M
EBITDA
53.34M
Earnings Per Share (EPS)
0.62

Cash Flow

In the last 12 months, operating cash flow was 46.04M and capital expenditures 36,000, giving a free cash flow of 46.07M billion.

Operating Cash Flow
46.04M
Free Cash Flow
46.07M
Free Cash Flow per Share
0.89

Dividends & Yields

Puma Biotechnology pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
12.51%
Earnings Yield
6.48%

Stock Price Statistics

Beta
1.17
52-Week Price Change
45.75%
50-Day Moving Average
9.66
200-Day Moving Average
8.06
Relative Strength Index (RSI)
24.97
Average Volume (3m)
379.16K

Important Dates

Puma Biotechnology upcoming earnings date is Mar 04, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 05, 2026
Next Earnings Date
Mar 04, 2027
Ex-Dividend Date
―

Financial Position

Puma Biotechnology as a current ratio of 2.00, with Debt / Equity ratio of 21.90%

Current Ratio
2.00
Quick Ratio
1.93
Debt to Market Cap
0.08
Net Debt to EBITDA
-0.02
Interest Coverage Ratio
5.63

Taxes

In the past 12 months, Puma Biotechnology has paid 4.67M in taxes.

Income Tax
4.67M
Effective Tax Rate
0.13

Enterprise Valuation

Puma Biotechnology EV to EBITDA ratio is 8.22, with an EV/FCF ratio of 7.20.

EV to Sales
1.43
EV to EBITDA
8.22
EV to Free Cash Flow
7.20
EV to Operating Cash Flow
7.21

Balance Sheet

Puma Biotechnology has $108.50M in cash and marketable securities with $4.87M in debt, giving a net cash position of $103.63M billion.

Cash & Marketable Securities
$108.50M
Total Debt
$4.87M
Net Cash
$103.63M
Net Cash Per Share
$2.00
Tangible Book Value Per Share
$2.18

Margins

Gross margin is 73.59%, with operating margin of 11.27%, and net profit margin of 10.28%.

Gross Margin
73.59%
Operating Margin
11.27%
Pretax Margin
12.12%
Net Profit Margin
10.28%
EBITDA Margin
17.40%
EBIT Margin
13.00%

Analyst Forecast

The average price target for Puma Biotechnology is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
9.35%
EPS Growth Forecast
-37.15%

Scores

Smart Score
7
AI Score
61